Product Name |
Recombinant Human Serum Amyloid A (SAA1) Protein |
Product Overview |
This recombinant human Serum Amyloid A (SAA1) protein includes amino acids 19-122aa of the target gene is expressed in E.coli.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
Target Uniprot Id |
P0DJI8 |
Recommended Name |
Serum amyloid A-1 protein |
Gene Name |
SAA1 |
Synonyms |
SAA1, PIG4, TP53I4 |
Species |
Human |
Predicted Molecular Mass |
13.9 kDa |
Expression System |
E.coli |
Expression Range |
19-122aa |
Purity |
>85% |
Formulation |
Lyophilized |
Buffer |
Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
Storage Condition |
1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
Reconstitution Instruction |
Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
Applications |
Positive Control; Immunogen; SDS-PAGE; WB |
Research Area |
Immunology |
Target Function |
Major acute phase protein. |
Subcellular Location |
Secreted. |
Protein Family |
SAA family |
Associated Diseases |
Reactive, secondary amyloidosis is characterized by the extracellular accumulation in various tissues of the SAA1 protein. These deposits are highly insoluble and resistant to proteolysis; they disrupt tissue structure and compromise function. |
Tissue Specificity |
Expressed by the liver; secreted in plasma (at protein level). |